Skip to main content

News and blog posts

16
Jun 2020

Specialized high-cost tariff-excluded devices (HCTED) program: Impact of the COVID19

NHS England is advising a temporary pause on any new migrations to the central supply route for high-cost tariff-excluded devices (HCTEDs) so that NHS suppliers can devote maximum operational effort to the COVID-19 action plan. If an NHS provider wants to complete an HCTED category migration, they will address this with their respective implementing manager for the NHS Supply Chain.
16
Jun 2020

New online seminar: Med Tech market access for non-market access professionals

MTRC released a novel product, which was often requested by our clients from marketing, market intelligence, clinical affairs and other non-market access departments. The online seminar includes a basic overview of the market access, clinical evidence, value claims management and health economics for the Med Tech non-market access professionals. Available in the form of presentation (89 slides) and a pre-recorded webinar (2.5 hours).
15
Jun 2020

Decisions about add-on reimbursement for medical devices in France in May 2020

The French High Authority for Health (HAS) regularly publishes new decisions about add-on reimbursement for medical devices. The decisions made in May 2020 concern various types of devices, including cardiovascular devices (self-expanding intracranial stents, TAVI), CT navigation kit for CT-guided percutaneous interventions and medical aids. A total of 8 decisions were made.
08
Jun 2020

New procedure codes implemented by the Dutch Healthcare Authority in 2020

New codes for Prostatic Urethral Lift system, CT and MRI examination of the neck, fecal microbiota transplant, testicular sperm extraction, implantable rechargeable and a non-rechargeable pulse generator for deep brain stimulation, as well as PET-CT myocardial perfusion with volume, ejection fraction and flow measurements and molecular diagnostics, were implemented in 2020.
05
Jun 2020

New software supporting sleep testing device (Brizzy) now available on mHealthBelgium

On May 4, 2020, a new web platform called Brizzy entered the level 1 of the mHealthBelgium validation pyramid. Brizzy (class IIa) sleep testing device allows diagnosing respiratory sleep disorders efficiently and accurately and avoids the complexity and discomfort associated with traditional systems. The web platform allows for the analysis of the assessment of the collected data.
02
Jun 2020

Reimbursement application portal for digital health apps is live in Germany

The application portal for inclusion in the directory of digital health apps (DiGA) at the Federal Office for Drugs and Medical Devices (BfArM) has been online since May 27, 2020. The application, which can be submitted only electronically, is the first step for the respective health app to be reimbursed in the future as part of regular care.